Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00096109 · TERMINATED
Trial details
- NCT number
- NCT00096109
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2012-05-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.